olanzapine and clopenthixol-decanoate

olanzapine has been researched along with clopenthixol-decanoate* in 1 studies

Other Studies

1 other study(ies) available for olanzapine and clopenthixol-decanoate

ArticleYear
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2

    Poor response to antipsychotics is still an important problem in the treatment of many schizophrenia patients. N-acetylcysteine (NAC) is a compound that exerts anti-oxidant and scavenging actions against reactive oxygen species. This paper reports a case of poorly responsive schizophrenia patient who improved considerably with add-on NAC 600 mg/day. The NAC might work through activating cysteine-glutamate antiporters or reducing in nitric oxide (NO) metabolites, free radicals and cytokines or through both of these mechanisms.

    Topics: Acetylcysteine; Adult; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

2009